Author | Charles F. Shaefer Jr, MD

Articles

ADA Posters: Incretins, SGLT2s, and New Fixed-dose Combos

June 19, 2014

Posters at ADA 2014 showcased growing popularity of the incretin therapies and SGLT2 inhibitors. Most fascinating to this diabetologist blogger was use of insulin and a GLP-1 RA in a fixed-combination product.